CoChat

Incretin levels in polycystic ovary syndrome

Vrbikova, Jana, Hill, Martin, Bendlova, Bela, Grimmichova, Tereza, Dvorakova, Katerina, Vondra, Karel, Pacini, Giovanni · 2008 · European Journal of Endocrinology

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Objective: Polycystic ovary syndrome (PCOS) has been linked to a high risk of type 2 diabetes mellitus. Disturbances in the secretion of the incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) have been observed in states with impaired glucose regulation. This paper considers the secretion of GIP and GLP-1 after oral glucose load in a group of lean, glucose-tolerant PCOS women in comparison with age- and body mass index (BMI)-matched healthy women. Design: Case control. Methods: PCOS (n=21, 25.8±4.1 years, BMI 21.6±1.7 kg/m 2) and control healthy women (CT, n=13, 28.5±7.2 years, BMI 20.3±2.5 kg/m 2) underwent oral glucose tolerance test (OGTT) with blood sampling for glucose, insulin, C-peptide, total GIP, and active GLP-1. Insulin sensitivity was determined both at fasting and during the test. Statistics: Repeated measures ANOVA. Results: Glucose levels and insulin sensitivity did not differ between PCOS and CT. PCOS had significantly higher levels of C-peptide (P<0.05) and tended to have higher insulin levels. The levels of total GIP were significantly higher in PCOS than in CT (P<0.001). Active GLP-1 levels exhibited a significantly different time-dependent pattern in PCOS (P<0.002 for PCOS versus time interaction). GLP-1 concentrations were similar in PCOS and CT in the early phase of OGTT and then reached significantly lower levels in PCOS than in CT at 180 min (P<0.05). Conclusions: Increased total GIP and lower late phase active GLP-1 concentrations during OGTT characterize PCOS women with higher C-peptide secretion in comparison with healthy controls, and may be the early markers of a pre-diabetic state.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje-08-0097

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Cited by

See all 81

Metadata

Authors
Vrbikova, J., Hill, M., Bendlova, B., Grimmichova, T., Dvorakova, K., Vondra, K., & Pacini, G.
Affiliations
Institute of Endocrinology (CZ)
Venue
European Journal of Endocrinology
Published
2008-08
Volume
159
Issue
2
Pages
121-127
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2132221299
Cited by
81
References
37
Citations by year
2026: 1 · 2025: 8 · 2024: 4 · 2023: 9 · 2022: 6 · 2021: 5 · 2020: 10 · 2019: 8 · 2018: 4 · 2017: 5 · 2016: 1 · 2015: 6 · 2014: 4 · 2013: 1 · 2012: 2
FWCI
2.71
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
polycystic ovary syndrome, incretins, glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, C-peptide, insulin sensitivity, oral glucose tolerance test, type 2 diabetes risk, prediabetes, lean women
MeSH terms
Adult, Blood Glucose, C-Peptide, Female, Gastric Inhibitory Polypeptide, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Polycystic Ovary Syndrome, Time Factors, Case-Control Studies, Glucagon-Like Peptide 1, Incretins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incretin levels in polycystic ovary syndrome. https://app.cochat.ai/papers/10.1530/eje-08-0097
The paper
Vrbikova, J., Hill, M., Bendlova, B., Grimmichova, T., Dvorakova, K., Vondra, K., & Pacini, G. (2008). Incretin levels in polycystic ovary syndrome. European Journal of Endocrinology. https://doi.org/10.1530/eje-08-0097

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.